Cleveland Clinic Taussig Cancer Institute

Taussig Cancer Institute is the hub for Cleveland Clinic Cancer Center.

 

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity
Avatar

Immunologic Basis of Adverse Events: Does Immunosuppression Used for Therapy of irAEs Compromise Anti-tumoral Immunity?

By Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity FEATURING Leonard Calabrese
By Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity FEATURING Leonard Calabrese
326 views
March 24, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Featured Video

20:59
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam
It Isn’t Just Joint Pain
21:50
Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

Adverse Events - Immunobiology of CPIs and Autoimmunity: PD-1 Pathwa…

Feat. L. Calabrese
16:28
Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

Immunologic Basis of Adverse Events: Does Immunosuppression Used for…

Feat. L. Calabrese
09:52
Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

Prospects of Targeted Therapy for Adverse Events: TNF, IL6, and T Ce…

Feat. L. Calabrese
19:05
Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

Rheumatic Immune Related Adverse Events from CPIs: Current and New T…

Feat. C. Calabrese
18:50
Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

62 y/o Male With Stage IV Renal Cell Carcinoma: Managing Rheumatic I…

Feat. E. Kirchner, C. Calabrese, L. Calabrese